钙通道阻滞剂与卒中  

Calcium-Channel Blockers and Stroke

作　　者：康力[1] 曾朝荣[1] 

机构地区：[1]成都市第七人民医院,四川成都610041

出　　处：《心血管病学进展》2008年第1期147-150,共4页Advances in Cardiovascular Diseases

摘　　要：高血压是卒中和其他心血管疾病最主要的可改变危险因素,随机对照试验支持使用抗高血压药物降低血压来预防卒中,对照试验荟萃分析证实,钙通道阻滞剂(CCB)预防卒中优于传统的抗高血压药物,现对CCBs与卒中的某些相关问题进行简要综述。High blood pressure is the most important modifiable risk factor for stroke and other vascular diseases. Evidence from randomized controlled trials supports the use of anti-hypertensive drugs to lower blood pressure for stroke prevention, in a meta-analysis of actively controlled trials, calcium-channel blockers resulted in better stroke prevention than the traditionally used drugs. This article reviews some issues related to calcium-channel blockers in cases of stroke.

关 键 词：钙通道阻滞剂 卒中 

分 类 号：R743.3[医药卫生—神经病学与精神病学]